- call +1-201-465-4211
- email sales@mrinsights.biz
Allergen diagnostics is identifying the allergy and preventing or curing the allergy at the different stages. Allergic diagnosis is segmented based on the different types i.e. from type I to type V. Type I allergy are those which take place primarily on epithelial surfaces which are skin, lungs, gastro intestinal track. Type IV are cellular reactions which involve T lymphocytes. The granulomatous type V allergy can be regarded as a variant of type IV allergy, as it also triggers a cell-mediated immune reaction, but involves macrophages instead of T lymphocytes.
Scope of the Report:
This report studies the Allergy Diagnostics And Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Allergy Diagnostics And Therapeutics market by product type and applications/end industries.
North America dominated the overall industry in terms of revenue in 2014 at over 39.0%. Higher incidence of respiratory allergic disorders, awareness level pertaining to allergy diagnostics and rising adoption of in vitro blood tests are attributing to the largest revenue share of this region. The European market is also expected to show positive growth due to developed pharmaceutical industry and increasing demand for therapeutics. Growing geriatric population and rising incidences of allergic conditions are also contributing to the aforementioned growth.
Asia-Pacific, on the other hand, is expected to be the fastest growing regional industry, by registering CAGR of over 12.0% in coming years due to the presence of high unmet needs, improvising healthcare infrastructure and demand for minimally invasive diagnostic tools from the consumer end.
The global Allergy Diagnostics And Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Allergy Diagnostics And Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
bioMerieux
Thermo Fisher Scientific
Danaher Corporation
Omega Diagnostics
Hitachi Chemical Diagnostics
Stallergenes Greer
Siemens Healthcare
Lincoln Diagnostics
Hycor Biomedical
HOB Biotech Group
Alcon Laboratories
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Instruments
Consumables
Services
Market Segment by Applications, can be divided into
Diagnostic Laboratories
Hospitals
Academic Research Institutes
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Allergy Diagnostics And Therapeutics Market Overview
1.1 Product Overview and Scope of Allergy Diagnostics And Therapeutics
1.2 Classification of Allergy Diagnostics And Therapeutics by Types
1.2.1 Global Allergy Diagnostics And Therapeutics Revenue Comparison by Types (2017-2023)
1.2.2 Global Allergy Diagnostics And Therapeutics Revenue Market Share by Types in 2017
1.2.3 Instruments
1.2.4 Consumables
1.2.5 Services
1.3 Global Allergy Diagnostics And Therapeutics Market by Application
1.3.1 Global Allergy Diagnostics And Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.3.4 Academic Research Institutes
1.4 Global Allergy Diagnostics And Therapeutics Market by Regions
1.4.1 Global Allergy Diagnostics And Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Allergy Diagnostics And Therapeutics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Allergy Diagnostics And Therapeutics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Allergy Diagnostics And Therapeutics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Allergy Diagnostics And Therapeutics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Allergy Diagnostics And Therapeutics Status and Prospect (2013-2023)
1.5 Global Market Size of Allergy Diagnostics And Therapeutics (2013-2023)
2 Manufacturers Profiles
2.1 bioMerieux
2.1.1 Business Overview
2.1.2 Allergy Diagnostics And Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 bioMerieux Allergy Diagnostics And Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Thermo Fisher Scientific
2.2.1 Business Overview
2.2.2 Allergy Diagnostics And Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Thermo Fisher Scientific Allergy Diagnostics And Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Danaher Corporation
2.3.1 Business Overview
2.3.2 Allergy Diagnostics And Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Danaher Corporation Allergy Diagnostics And Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Omega Diagnostics
2.4.1 Business Overview
2.4.2 Allergy Diagnostics And Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Omega Diagnostics Allergy Diagnostics And Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Hitachi Chemical Diagnostics
2.5.1 Business Overview
2.5.2 Allergy Diagnostics And Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Hitachi Chemical Diagnostics Allergy Diagnostics And Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Stallergenes Greer
2.6.1 Business Overview
2.6.2 Allergy Diagnostics And Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Stallergenes Greer Allergy Diagnostics And Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Siemens Healthcare
2.7.1 Business Overview
2.7.2 Allergy Diagnostics And Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Siemens Healthcare Allergy Diagnostics And Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Lincoln Diagnostics
2.8.1 Business Overview
2.8.2 Allergy Diagnostics And Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Lincoln Diagnostics Allergy Diagnostics And Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Hycor Biomedical
2.9.1 Business Overview
2.9.2 Allergy Diagnostics And Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Hycor Biomedical Allergy Diagnostics And Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.10 HOB Biotech Group
2.10.1 Business Overview
2.10.2 Allergy Diagnostics And Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 HOB Biotech Group Allergy Diagnostics And Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.11 Alcon Laboratories
2.11.1 Business Overview
2.11.2 Allergy Diagnostics And Therapeutics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Alcon Laboratories Allergy Diagnostics And Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
3 Global Allergy Diagnostics And Therapeutics Market Competition, by Players
3.1 Global Allergy Diagnostics And Therapeutics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Allergy Diagnostics And Therapeutics Players Market Share
3.2.2 Top 10 Allergy Diagnostics And Therapeutics Players Market Share
3.3 Market Competition Trend
4 Global Allergy Diagnostics And Therapeutics Market Size by Regions
4.1 Global Allergy Diagnostics And Therapeutics Revenue and Market Share by Regions
4.2 North America Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
4.3 Europe Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
4.5 South America Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
5 North America Allergy Diagnostics And Therapeutics Revenue by Countries
5.1 North America Allergy Diagnostics And Therapeutics Revenue by Countries (2013-2018)
5.2 USA Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
5.3 Canada Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
5.4 Mexico Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
6 Europe Allergy Diagnostics And Therapeutics Revenue by Countries
6.1 Europe Allergy Diagnostics And Therapeutics Revenue by Countries (2013-2018)
6.2 Germany Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
6.3 UK Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
6.4 France Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
6.5 Russia Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
6.6 Italy Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Allergy Diagnostics And Therapeutics Revenue by Countries
7.1 Asia-Pacific Allergy Diagnostics And Therapeutics Revenue by Countries (2013-2018)
7.2 China Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
7.3 Japan Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
7.4 Korea Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
7.5 India Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
8 South America Allergy Diagnostics And Therapeutics Revenue by Countries
8.1 South America Allergy Diagnostics And Therapeutics Revenue by Countries (2013-2018)
8.2 Brazil Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
8.3 Argentina Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
8.4 Colombia Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Allergy Diagnostics And Therapeutics by Countries
9.1 Middle East and Africa Allergy Diagnostics And Therapeutics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
9.3 UAE Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
9.4 Egypt Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
9.6 South Africa Allergy Diagnostics And Therapeutics Revenue and Growth Rate (2013-2018)
10 Global Allergy Diagnostics And Therapeutics Market Segment by Type
10.1 Global Allergy Diagnostics And Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Global Allergy Diagnostics And Therapeutics Market Forecast by Type (2018-2023)
10.3 Instruments Revenue Growth Rate (2013-2023)
10.4 Consumables Revenue Growth Rate (2013-2023)
10.5 Services Revenue Growth Rate (2013-2023)
11 Global Allergy Diagnostics And Therapeutics Market Segment by Application
11.1 Global Allergy Diagnostics And Therapeutics Revenue Market Share by Application (2013-2018)
11.2 Allergy Diagnostics And Therapeutics Market Forecast by Application (2018-2023)
11.3 Diagnostic Laboratories Revenue Growth (2013-2018)
11.4 Hospitals Revenue Growth (2013-2018)
11.5 Academic Research Institutes Revenue Growth (2013-2018)
12 Global Allergy Diagnostics And Therapeutics Market Size Forecast (2018-2023)
12.1 Global Allergy Diagnostics And Therapeutics Market Size Forecast (2018-2023)
12.2 Global Allergy Diagnostics And Therapeutics Market Forecast by Regions (2018-2023)
12.3 North America Allergy Diagnostics And Therapeutics Revenue Market Forecast (2018-2023)
12.4 Europe Allergy Diagnostics And Therapeutics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Allergy Diagnostics And Therapeutics Revenue Market Forecast (2018-2023)
12.6 South America Allergy Diagnostics And Therapeutics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Allergy Diagnostics And Therapeutics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Allergy Diagnostics And Therapeutics Picture
Table Product Specifications of Allergy Diagnostics And Therapeutics
Table Global Allergy Diagnostics And Therapeutics a
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
